General Medicine

Endocrinology and metabolism

Our projects cover the spectrum from small studies of rare metabolic diseases to Type 2 diabetes mega-trials enrolling thousands. We fulfill the unique needs of each study with strong site networks around the world and recruitment solutions, including both adult and pediatric studies. Sensor solutions for diabetes studies are another area of our expertise, including 21 Code of Federal Regulations (CFR) part 11–compliant continuous glucose monitoring (CGM). Our sensor solutions and endocrinology experts have collaborated on solutions to facilitate CGM and glucose-related data capture for diabetes clinical trials. Through partnerships with our vendors, we can offer an integrated central platform for real-time visualization and monitoring of CGM, blood glucose and e-diary information.

Our team includes board-certified adult and pediatric endocrinologists, certified clinical densitometrists, glucose-clamp expertise, and top-quality regulatory, market access, and biostatistics experts.

Nephrology and genito-urinary

As we enter a new era with breakthroughs for chronic kidney and urinary system diseases, we are here to help you overcome obstacles — like patient recruitment, payer engagement, and others. Our delivery of major studies in this area demonstrates expertise, including chronic kidney failure, diabetic and polycystic kidney diseases, nephritis, nephropathy, urinary incontinence, overactive bladder, and benign prostatic hyperplasia.

Respiratory

From the millions of individuals affected by asthma and COPD to the few affected by rare diseases, bringing innovation and more affordable treatments to patients is our passion. At Parexel, we have conducted studies in common repsiratory processes involving many thousands of patients at more than 3,000 sites globally, including one of the largest observational asthma trials ever conducted. Likewise, our expertise spans to smaller studies in interstitial lung disease, cystic fibrosis, chronic cough, and orphan diseases.

Through partnerships with the leading pharma companies and biotech innovators, we collaborate across the full ecosystem of respiratory disease research. As a single point of contact, we integrate meaningful data to assess treatment efficacy in an interventional trial and relevant insights in the real world of respiratory disease.

Women’s health

While the ecosystem for women’s health drug development and marketed products has become increasingly complex, we have the experience and success to drive your trials forward. Our expertise spans across a person’s lifetime, encompassing preadolescent care, menstrual and pelvic health, contraception, fertility, pregnancy, menopausal care, and mental health. We continue to be at the cutting edge of women’s health, supporting all three women’s health products approved by the US FDA in 2020. As the field of women’s health moves beyond patients, health care providers, pharma, payors, and regulators, we are ready to partner with you to accelerate product development.